A. Endo et al., Cardiac and plasma catecholamine responses to exercise in patients with type 2 diabetes: Prognostic implications for cardiac-cerebrovascular events, AM J MED SC, 320(1), 2000, pp. 24-30
Citations number
31
Categorie Soggetti
General & Internal Medicine","Medical Research General Topics
Background: Patients with diabetes mellitus have an altered exercise plasma
catecholamine response, which may be related to the abnormal sympathoadren
al function and autonomic neuropathy. Presence of autonomic neuropathy is a
ssociated with poor prognosis, but relationship between exercise plasma cat
echolamine and prognosis has not been investigated. This study determined i
f altered plasma catecholamine response to exercise was associated with car
diac-cerebrovascular events. Methods: Forty patients with type 2 diabetes w
ithout apparent macrovascular complications and 30 control subjects perform
ed treadmill exercise with serial measurements of plasma norepinephrine and
epinephrine. Clinical, exercise, and catecholaminergic variables considere
d relevant to the cardiac-cerebrovascular events were examined by Cox regre
ssion model. Analysis of 24-hour heart rate variability was performed in a
subgroup of patients. Results: During 7.2 years, 8 patients, but no control
subjects, had events (3 myocardial and 5 cerebral infarctions). Compared w
ith Event(-) patients, Event(+) patients had: (1) orthostatic hypotension;
(2) lower peak exercise heart rate; (3) lower plasma norepinephrine immedia
tely after exercise; and (4) lower plasma epinephrine at peak exercise. Hig
h frequency components in heart rate variability analysis were diminished i
n Event(+) patients. Multivariate analysis-showed that peak heart rate (P =
0.04) and plasma epinephrine at peak exercise (P = 0.03) were independent
predictors of subsequent events. Conclusions: These data suggest that chron
otropic incompetence and lower plasma epinephrine response to exercise are
associated with high risk of card iac-cerebrovascular events in patients wi
th type 2 diabetes.